Ironwood Pharmaceuticals

IRWDNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$747.711 M

$4.53 +2.61%

Close of 22 Sept 2026

Revenue

$296.2M

#2136 by revenue

Earnings

$24.0M

#1808 by earnings

Shares outstanding

165,239,947

Latest filing cover page

P/E ratio

31.1

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#181VerastemVSTM$758.0M
#182Nuvectis PharmaNVCT$750.1M
#183Ironwood PharmaceuticalsIRWD$747.7M
#184Collegium PharmaceuticalCOLL$741.6M
#185MapLight TherapeuticsMPLT$703.4M

What if Ironwood Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.2T

$182,970.10

Per share 40,435× higher

Bitcoin $1.74T

$10,540.16

Per share 2,329× higher

Nvidia $5.52T

$33,380.35

Per share 7,377× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for Ironwood Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.